Document is current
Any future updates will be listed below
-
Authors
Godet, Thomas https://orcid.org/0000-0002-9667-3407
Louis, Clémence
Rieu, Benjamin
De Jong, Audrey https://orcid.org/0000-0002-3413-2752
Couhault, Pierre
Pradel, Gaël https://orcid.org/0000-0003-2027-6218
Tête, Hugo
Bourguignon, Nathalie
Borao, Lucile
Jabaudon, Matthieu
Futier, Emmanuel https://orcid.org/0000-0002-6454-271X
Jaber, Samir https://orcid.org/0000-0002-7257-8069
Pereira, Bruno https://orcid.org/0000-0003-3778-7161
Chanques, Gérald
Constantin, Jean-Michel https://orcid.org/0000-0001-7634-5898
,
Assefi, Mona
Chabanne, Russell
Garnier, Marc
Rouget, Antoine
Souweine, Bertrand
Piot L’Emeillet, Juliette
Lapeyre, Mathilde
Thourot-Robert, Manon
Bernard, Lise
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03317067 at ClinicalTrials.govDocuments that mention this clinical trial
Dexmedetomidine for treatment of hyperactive delirium in non-intubated ICU patients: the 4D randomized clinical trial
https://doi.org/10.1007/s00134-025-08135-1
-
Funding
Funding for this research was provided by:
PHRCI (2018)
- License Information
-
More Information
Article History
Received: 19 June 2025
Accepted: 23 September 2025
First Online: 29 October 2025
Declarations
:
: SJ is the Editor in Chief of Intensive Care Medicine. He has not taken part in the review or selection process of this article. Dr. De Jong reports receiving speaker fees from Medtronic, Sanofi, Fisher and Paykel Healthcare, Sedana Medical, Viatris, and Mindray. Dr. Couhault reports receiving lecture fees from AOP Health. Dr. Jabaudon reports receiving lecture and consulting fees from Abbvie and Sedana Medical. Dr. Rieu reports receiving travel fees and honoraria from LFB Biomédicaments. Dr. Godet reports receiving lecture and consulting fees from General Electrics Healthcare, Dräger, Fisher and Paykel Healthcare, Edwards Lifescience, AOP Health, and Aspen Pharma. Dr. Futier reports receiving consulting fees from General Electrics Healthcare and Dräger. Dr. Jaber reports consulting fees from Dräger, Mindray, Medtronic, Baxter, Fresenius-Xenios, and Fisher and Paykel Healthcare. Dr. Chanques reports no conflict of interest. Dr. Constantin reports receiving lecture and consulting fees from Sedana Medical, Baxter, General Electrics Healthcare, Dräger, Lowenstein, AOP Health, Gilead, Mindray, Shionogi, Fisher and Paykel Healthcare, Viasys, and LFB Biomédicaments. The remaining authors have no conflicts of interest to declare.
